Autres langues IntegraGen

Actions

ALINT

FR0010908723

Recherche biotechnologique et médicale

PEA

PEA/PME

Marché Fermé - Euronext Paris 17:55:00 11/09/2026			Varia. 5j.	Varia. 1 janv.
0,1995 ^EUR	-8,90 %		+11,45 %	+50,00 %

11/09	ABL Diagnostics propose de racheter IntegraGen dans le cadre d'une procédure de redressement judiciaire	MT
16/06	Bourse : tensions entre Unicredit et l'Allemagne, SpaceX flambe (encore), Bénéteau au régime

Autres langues

11/09	ABL Diagnostics Société anonyme proposed to acquire Business operations and assets of IntegraGen SA.
11/09	ABL Diagnostics Offers to Acquire IntegraGen Amid Reorganization Proceedings
24/04	SSH Communications Security, Intragen Enter European Data Sovereignty Partnership
23/04	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2025
30/10/25	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2025
02/07/25	IntegraGen SA Not Maintains Revenue Guidance for the Full Year of 2025
02/07/25	IntegraGen SA Reports Sales Results for the First Half of 2025
02/07/25	IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million
02/07/25	IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million
29/04/25	IntegraGen: 2024 Annual Results
29/04/25	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2024
15/01/25	IntegraGen : Inside Information / Information on annual revenues
15/01/25	IntegraGen SA Announces Unaudited Revenue Results for the Year 2024
15/01/25	IntegraGen: 2024 Revenues of €8.5m, Down 27% Compared With 2023 (+5% Excluding SeqOIA), and Cash Position of €1.9m
17/10/24	IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained
30/07/24	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2024
24/07/24	IntegraGen : reports €4.5m in revenues for H1 2024 representing 6% increase compared to H1 2023 and a cash position of €2.8m
19/07/24	Borsa di Italia: Addio a Joe?
19/07/24	Bolsa de Madrid: ¿Adiós, Joe?
18/07/24	IntegraGen Reports Sales Results for the First-Half of 2024
18/07/24	IntegraGen: First-Half 2024 Sales of €4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of €2.8m
01/05/24	IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2023
18/04/24	IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control
23/10/23	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023
13/07/23	IntegraGen SA Announces Revenue Results for the First Half of 2023